We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





AI Model for Early Detection of SARS-CoV-2 in Children Could Pave Way for Rapid Bedside COVID-19 Diagnostic Device

By LabMedica International staff writers
Posted on 05 Feb 2021
Print article
Illustration
Illustration
An artificial intelligence (AI) model to aid in the early detection of severe SARS-CoV2 illness in children is expected to improve outcomes via early recognition, timely intervention and appropriate allocation of critical resources, as well as lead to the development of a rapid bedside COVID-19 diagnostic device.

To prevent children from becoming critically ill from SARS-CoV-2, a team of researchers at Wayne State University (Detroit, MI, USA) is working to define and compare the salivary molecular host response in children with varying phenotypes of SARS-CoV-2 infections and develop and validate a sensitive and specific model to predict severe SARS-CoV-2 illness in children. They are working to develop a portable, rapid device that quantifies salivary miRNAs with comparable accuracy to predicate technology (qRT-PCR). The team will develop an AI-assisted cloud and mobile system for early recognition of severe SARS-CoV-2 infection in children.

Currently, there are no methods to discern the spectrum of the disease’s severity and predict which children with SARS-CoV-2 exposure will develop severe illness, including Multisystem Inflammatory Syndrome (MIS-C). Because of this, there is an urgent need to develop a diagnostic modality to distinguish the varying phenotypes of disease and risk stratify disease. The research team aims to develop an innovative and efficient AI model with cloud and edge intelligence-integrating non-invasive biomarkers with social determinants of health and clinical data to aid with early detection of severe SARS-CoV-2 illness in children.

“Our research is critical as we expect to improve outcomes of children with severe SARS-CoV-2 infection via early recognition, timely intervention and appropriate allocation of critical resources,” said Dongxiao Zhu, Ph.D., associate professor of computer science in the College of Engineering, who is leading the study. “The successful completion of the project will also be significant, as it will lead to the development of a rapid bedside diagnostic device and creation of patient profiles based on individual risk factors which we expect to lead to personalized treatments in the future.”


Related Links:
Wayne State University

Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chagas Disease Test
LIAISON Chagas
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The researchers detected genomic alterations from plasma cfDNA (Photo courtesy of 123RF)

Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors

Current circulating cell-free DNA (cfDNA) assays are typically centralized, requiring specialized handling and transportation of samples. Introducing a flexible, decentralized sequencing system at the... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.